Pharmacokinetics and consistency of pericardial delivery directed to coronary arteries: Direct comparison with endoluminal delivery

Hans Peter Stoll, Kathy Carlson, Larry K. Keefer, Joseph A. Hrabie, Keith L. March

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background and hypothesis: Pharmacologic modulation of the contents of the pericardial space has been shown to influence the response of coronary arteries to balloon injury. Endoluminal (EL) local delivery of various drags into coronaries has been found to be limited by short residence time, as well as by highly variable deposited agent concentration. We hypothesized that compounds placed into the pericardial space (P) would penetrate into coronary tissue with greater consistency than seen after EL delivery, and provide for prolonged coronary exposure to agents. Methods and Results: 125I-labeled basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), albumin, or 131I-labeled diazeniumdiolated albumin (NONO-albumin) were delivered as model/therapeutic proteins into the porcine pericardial space (n = 15 pigs) or into coronaries using an EL delivery catheter (n = 48 arteries). In subjects receiving 125I-labeled proteins, the delivery target or mid-regions of the left anterior descending (LAD) and left circumflex (LCx) arteries were harvested at I h or 24 h for gamma-counting and autoradiography, and fractional intramural delivery (FID) or retention measured as percent agent in 100 mg artery/agent in infusate for both time points. In the animals receiving 131I-labeled NONO-albumin, serial gamma imaging was employed to evaluate the rate of redistribution in individual animals following either pericardial or endoluminal delivery. At 1 h, FID values ranged from 0.00064 to 0052% for P delivery (median 0.0022%), and from 0.00021 to 6.7 for EL delivery (median 0.27%). At 24 h, FID values ranged from 0.00011 to 0.003 for P delivery (median 0.0013), and from 0.0002 to 1.4 for EL delivery. The estimated T 1/2 for bFGF redistribution from the vascular tissue was 22 h (P) and 7 h (EL), respectively, while the directly determined T 1/2 values for NONO-albumin redistribution from the delivery region were 22.2 h (P) and 2.5 h (EL). Conclusions: These data show that pericardial fluid contents can access coronary arteries with intramural concentrations which typically vary by 10-15-fold, while EL delivery results in a remarkably wide intramural concentration range with up to 33,000-fold variability. The apparent redistribution rate is more rapid following EL delivery, possibly due to sustained diffusive tissue loading from the pericardial space. Pericardial delivery appears to offer substantial advantages over EL administration with respect to residence time and reproducibility.

Original languageEnglish (US)
JournalClinical Cardiology
Volume22
Issue number1 SUPPL.
StatePublished - Jan 1999

Fingerprint

Pericardium
Coronary Vessels
Pharmacokinetics
Arteries
Fibroblast Growth Factor 2
Albumins
Swine
Platelet-Derived Growth Factor
Autoradiography
Blood Vessels
Proteins
Catheters
Wounds and Injuries
(131)I-labeled diazeniumdiolated albumin
Therapeutics

Keywords

  • Angiogenesis
  • Coronary disease
  • Local drag delivery
  • Pericardium
  • Restenosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Pharmacokinetics and consistency of pericardial delivery directed to coronary arteries : Direct comparison with endoluminal delivery. / Stoll, Hans Peter; Carlson, Kathy; Keefer, Larry K.; Hrabie, Joseph A.; March, Keith L.

In: Clinical Cardiology, Vol. 22, No. 1 SUPPL., 01.1999.

Research output: Contribution to journalArticle

Stoll, Hans Peter ; Carlson, Kathy ; Keefer, Larry K. ; Hrabie, Joseph A. ; March, Keith L. / Pharmacokinetics and consistency of pericardial delivery directed to coronary arteries : Direct comparison with endoluminal delivery. In: Clinical Cardiology. 1999 ; Vol. 22, No. 1 SUPPL.
@article{b8a233809f444f92b41e87d362a38273,
title = "Pharmacokinetics and consistency of pericardial delivery directed to coronary arteries: Direct comparison with endoluminal delivery",
abstract = "Background and hypothesis: Pharmacologic modulation of the contents of the pericardial space has been shown to influence the response of coronary arteries to balloon injury. Endoluminal (EL) local delivery of various drags into coronaries has been found to be limited by short residence time, as well as by highly variable deposited agent concentration. We hypothesized that compounds placed into the pericardial space (P) would penetrate into coronary tissue with greater consistency than seen after EL delivery, and provide for prolonged coronary exposure to agents. Methods and Results: 125I-labeled basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), albumin, or 131I-labeled diazeniumdiolated albumin (NONO-albumin) were delivered as model/therapeutic proteins into the porcine pericardial space (n = 15 pigs) or into coronaries using an EL delivery catheter (n = 48 arteries). In subjects receiving 125I-labeled proteins, the delivery target or mid-regions of the left anterior descending (LAD) and left circumflex (LCx) arteries were harvested at I h or 24 h for gamma-counting and autoradiography, and fractional intramural delivery (FID) or retention measured as percent agent in 100 mg artery/agent in infusate for both time points. In the animals receiving 131I-labeled NONO-albumin, serial gamma imaging was employed to evaluate the rate of redistribution in individual animals following either pericardial or endoluminal delivery. At 1 h, FID values ranged from 0.00064 to 0052{\%} for P delivery (median 0.0022{\%}), and from 0.00021 to 6.7 for EL delivery (median 0.27{\%}). At 24 h, FID values ranged from 0.00011 to 0.003 for P delivery (median 0.0013), and from 0.0002 to 1.4 for EL delivery. The estimated T 1/2 for bFGF redistribution from the vascular tissue was 22 h (P) and 7 h (EL), respectively, while the directly determined T 1/2 values for NONO-albumin redistribution from the delivery region were 22.2 h (P) and 2.5 h (EL). Conclusions: These data show that pericardial fluid contents can access coronary arteries with intramural concentrations which typically vary by 10-15-fold, while EL delivery results in a remarkably wide intramural concentration range with up to 33,000-fold variability. The apparent redistribution rate is more rapid following EL delivery, possibly due to sustained diffusive tissue loading from the pericardial space. Pericardial delivery appears to offer substantial advantages over EL administration with respect to residence time and reproducibility.",
keywords = "Angiogenesis, Coronary disease, Local drag delivery, Pericardium, Restenosis",
author = "Stoll, {Hans Peter} and Kathy Carlson and Keefer, {Larry K.} and Hrabie, {Joseph A.} and March, {Keith L.}",
year = "1999",
month = "1",
language = "English (US)",
volume = "22",
journal = "Clinical Cardiology",
issn = "0160-9289",
publisher = "John Wiley and Sons Inc.",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Pharmacokinetics and consistency of pericardial delivery directed to coronary arteries

T2 - Direct comparison with endoluminal delivery

AU - Stoll, Hans Peter

AU - Carlson, Kathy

AU - Keefer, Larry K.

AU - Hrabie, Joseph A.

AU - March, Keith L.

PY - 1999/1

Y1 - 1999/1

N2 - Background and hypothesis: Pharmacologic modulation of the contents of the pericardial space has been shown to influence the response of coronary arteries to balloon injury. Endoluminal (EL) local delivery of various drags into coronaries has been found to be limited by short residence time, as well as by highly variable deposited agent concentration. We hypothesized that compounds placed into the pericardial space (P) would penetrate into coronary tissue with greater consistency than seen after EL delivery, and provide for prolonged coronary exposure to agents. Methods and Results: 125I-labeled basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), albumin, or 131I-labeled diazeniumdiolated albumin (NONO-albumin) were delivered as model/therapeutic proteins into the porcine pericardial space (n = 15 pigs) or into coronaries using an EL delivery catheter (n = 48 arteries). In subjects receiving 125I-labeled proteins, the delivery target or mid-regions of the left anterior descending (LAD) and left circumflex (LCx) arteries were harvested at I h or 24 h for gamma-counting and autoradiography, and fractional intramural delivery (FID) or retention measured as percent agent in 100 mg artery/agent in infusate for both time points. In the animals receiving 131I-labeled NONO-albumin, serial gamma imaging was employed to evaluate the rate of redistribution in individual animals following either pericardial or endoluminal delivery. At 1 h, FID values ranged from 0.00064 to 0052% for P delivery (median 0.0022%), and from 0.00021 to 6.7 for EL delivery (median 0.27%). At 24 h, FID values ranged from 0.00011 to 0.003 for P delivery (median 0.0013), and from 0.0002 to 1.4 for EL delivery. The estimated T 1/2 for bFGF redistribution from the vascular tissue was 22 h (P) and 7 h (EL), respectively, while the directly determined T 1/2 values for NONO-albumin redistribution from the delivery region were 22.2 h (P) and 2.5 h (EL). Conclusions: These data show that pericardial fluid contents can access coronary arteries with intramural concentrations which typically vary by 10-15-fold, while EL delivery results in a remarkably wide intramural concentration range with up to 33,000-fold variability. The apparent redistribution rate is more rapid following EL delivery, possibly due to sustained diffusive tissue loading from the pericardial space. Pericardial delivery appears to offer substantial advantages over EL administration with respect to residence time and reproducibility.

AB - Background and hypothesis: Pharmacologic modulation of the contents of the pericardial space has been shown to influence the response of coronary arteries to balloon injury. Endoluminal (EL) local delivery of various drags into coronaries has been found to be limited by short residence time, as well as by highly variable deposited agent concentration. We hypothesized that compounds placed into the pericardial space (P) would penetrate into coronary tissue with greater consistency than seen after EL delivery, and provide for prolonged coronary exposure to agents. Methods and Results: 125I-labeled basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), albumin, or 131I-labeled diazeniumdiolated albumin (NONO-albumin) were delivered as model/therapeutic proteins into the porcine pericardial space (n = 15 pigs) or into coronaries using an EL delivery catheter (n = 48 arteries). In subjects receiving 125I-labeled proteins, the delivery target or mid-regions of the left anterior descending (LAD) and left circumflex (LCx) arteries were harvested at I h or 24 h for gamma-counting and autoradiography, and fractional intramural delivery (FID) or retention measured as percent agent in 100 mg artery/agent in infusate for both time points. In the animals receiving 131I-labeled NONO-albumin, serial gamma imaging was employed to evaluate the rate of redistribution in individual animals following either pericardial or endoluminal delivery. At 1 h, FID values ranged from 0.00064 to 0052% for P delivery (median 0.0022%), and from 0.00021 to 6.7 for EL delivery (median 0.27%). At 24 h, FID values ranged from 0.00011 to 0.003 for P delivery (median 0.0013), and from 0.0002 to 1.4 for EL delivery. The estimated T 1/2 for bFGF redistribution from the vascular tissue was 22 h (P) and 7 h (EL), respectively, while the directly determined T 1/2 values for NONO-albumin redistribution from the delivery region were 22.2 h (P) and 2.5 h (EL). Conclusions: These data show that pericardial fluid contents can access coronary arteries with intramural concentrations which typically vary by 10-15-fold, while EL delivery results in a remarkably wide intramural concentration range with up to 33,000-fold variability. The apparent redistribution rate is more rapid following EL delivery, possibly due to sustained diffusive tissue loading from the pericardial space. Pericardial delivery appears to offer substantial advantages over EL administration with respect to residence time and reproducibility.

KW - Angiogenesis

KW - Coronary disease

KW - Local drag delivery

KW - Pericardium

KW - Restenosis

UR - http://www.scopus.com/inward/record.url?scp=0032940926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032940926&partnerID=8YFLogxK

M3 - Article

C2 - 9929762

AN - SCOPUS:0032940926

VL - 22

JO - Clinical Cardiology

JF - Clinical Cardiology

SN - 0160-9289

IS - 1 SUPPL.

ER -